Cancer Research UK logo.
SearchDonate
  • Search

A trial of durvalumab after treatment for bladder cancer (BL13)

Overview

Cancer types:

Bladder cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for people who have had surgery, chemotherapy and radiotherapy for bladder cancer that has grown into the muscle wall. This is called muscle invasive bladder cancer.

Cancer Research UK supports this trial.

Recruitment start: 31 August 2020

Recruitment end: 13 January 2023

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Simon Crabb

Supported by

AstraZeneca

Cancer Research UK

University Hospital Southampton NHS Foundation Trust

Canadian Cancer Trials Group (CCTG)

Other information

This is Cancer Research UK trial number CRUKE/18/013.

Last reviewed: 26 April 2023

CRUK internal database number: 16451

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.